EquityZen Growth Technology Fund LLC - Series 721
Raised
$270K
Investors
9
Min Invest
$10,017
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 721 is a Delaware LLC filed July 1, 2021, raising $270K from 9 investors under Rule 506(b) and Section 3(c)(1). The vehicle is part of the EquityZen platform, a pre-IPO secondary marketplace with over 1,800 related EDGAR entities, and features a $10K minimum investment. Management is provided by EquityZen Advisors LLC with oversight by Assure Fund Management II LLC.
This single-deal SPV operates within the pre-IPO secondary market segment, employing the standard 506(b)/3(c)(1) exemption structure common to EquityZen's serialized fund family. The $10K minimum investment represents the accessible retail tier typical of platform-enabled pre-IPO vehicles, contrasting with institutional pre-IPO funds that often require $250K+ minimums.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
